Anand Kapila K 4

What Happened

• Anand Kapila K, a director of Omega Healthcare Investors, was granted 6,205 deferred stock units (derivative securities) on 2026-06-05. The reported acquisition price is $0.00 (an award/grant, not a purchase). These units are recorded as convertible to common shares on a one-for-one basis.

Key Details

• Transaction date and price: 2026-06-05, 6,205 units at $0.00 (award/derivative).
• Filing: Form 4 filed 2026-06-09 for the 2026-06-05 grant (appears later than the typical 2-business-day Form 4 deadline — may be a late filing).
• Shares owned after transaction: not specified in the provided filing details.
• Notable footnotes from the filing:
  • F1: Units convert into shares of common stock on a one-to-one basis; dividends may be converted into Deferred Stock Units if the participant elects.
  • F2: These units are the annual restricted stock grant elected to be taken as Deferred Stock Units and are restricted from transfer/sale until Omega’s 2027 Annual Meeting (the vesting date).
  • F3/F4: Additional standard restrictions/conversion-on-separation provisions apply per plan (units convert on separation, death, disability, or specified events).

Context

• This was an award (grant) of deferred/restricted units, not an open-market purchase or sale; such grants are common for director compensation and do not by themselves indicate a buy/sell market signal. The units will convert to common shares on vesting or under specified circumstances described in the plan.